Ulrich Flgel1, Sara Tucci2,
Jrgen Schrader1, Ute Spiekerkoetter2
Therapeutical approaches to limit metabolic derangement in patients with long chain fatty acid oxidation disorders (LCAD) include fat-modified diets, in which long-chain triglycerides are replaced by medium-chain triglycerides (MCT). The present study investigated the effects of a long-term MCT therapy on body lipid homeostasis using 1H MRI and 1H/13C MRS in a murine model of LCAD. One year MCT-based diet resulted in massive visceral fat infiltration, impaired body fat composition, and steatohepatitis. Although MCT diet has been reported to prevent development of cardiomyopathy and the myopathic phenotype, according to our data its use and dose has to be well considered.